Perinatal group B streptococcal colonization and infection

Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 1):617-20. doi: 10.1016/s0002-9378(16)32429-2.

Abstract

Of 2,169 patients screened in labor for vaginal group B streptococcal colonization, 164 (7.6%) had positive results. Five hundred twenty-four of the patients were screened in the antenatal period, and 57 patients with positive tests for group B streptococcus were treated in labor with intravenous ampicillin. Four of the treatment group gave birth to colonized infants but none became infected. Of the 136 untreated mother-infant pairs with positive tests, 62 neonates were colonized, nine became infected, and three died. In the presence of an attack rate of 6.6% among infants born to colonized mothers, antenatal screening and treatment in labor of mothers colonized with group B streptococcus will reduce neonatal colonization and infection.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ampicillin / therapeutic use
  • Delivery, Obstetric
  • Ear / microbiology
  • Female
  • Humans
  • Infant Mortality
  • Infant, Newborn
  • Infant, Newborn, Diseases / diagnosis
  • Infant, Newborn, Diseases / drug therapy
  • Infant, Newborn, Diseases / microbiology*
  • Labor, Obstetric
  • Mass Screening
  • Pregnancy
  • Pregnancy Trimester, Second
  • Pregnancy Trimester, Third
  • Streptococcal Infections / diagnosis*
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / transmission
  • Streptococcus agalactiae / isolation & purification*
  • Umbilicus / microbiology
  • Vagina / microbiology

Substances

  • Ampicillin